SCHEMBL8480424

SCHEMBL8480424

CCCn1cnc2c1c(=O)n(CC(C)(O)C#CCN(CC)CC)c(=O)n2C

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 12/20 0.51
▸ LMNA P02545 2/20 0.51
▸ ESR1 P03372 1/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ MAPT P10636 1/20 0.51
▸ NFKB1 P19838 1/20 0.51
▸ ACHE P22303 1/20 0.51
▸ BLM P54132 1/20 0.51
▸ PMP22 Q01453 1/20 0.51
▸ PDE4B Q07343 11/20 0.49
▸ PDE4C Q08493 11/20 0.49
▸ PDE4D Q08499 11/20 0.49
▸ ADORA2A P29274 6/20 0.49
▸ ADORA2B P29275 6/20 0.49
▸ TRPA1 O75762 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL8479729 0.94 PDE4A (0.48) PDE4ALMNAESR1CYP1A2MAPT
Fumaric Acid SCHEMBL8479723 0.94 PDE4A (0.48) PDE4ALMNAESR1CYP1A2MAPT
SCHEMBL8483261 0.93 PDE4A (0.53) PDE4ACYP1A2BLMPMP22PDE4B
SCHEMBL8480538 0.89 PDE4A (0.57) PDE4ALMNAESR1CYP1A2MAPT
SCHEMBL8479457 0.88 PDE4A (0.56) PDE4ALMNAESR1CYP1A2MAPT
Hydrochloric Acid SCHEMBL8480119 0.88 PDE4A (0.56) PDE4ALMNAESR1CYP1A2MAPT
Hydrochloric Acid SCHEMBL8484711 0.87 PDE4A (0.56) PDE4ALMNAESR1CYP1A2MAPT
SCHEMBL8482153 0.87 PDE4A (0.52) PDE4ALMNAESR1CYP1A2MAPT
Hydrochloric Acid SCHEMBL8485311 0.86 PDE4A (0.52) PDE4ALMNAESR1CYP1A2MAPT
SCHEMBL8482531 0.85 PDE4A (0.56) PDE4ALMNAESR1CYP1A2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5965555-A TREATMENT AND/OR PROPHYLAXIS OF CEREBROVASCULAR DISORDERS CHARACTERIZED BY DAMAGE CAUSED BY ISCHEMIA AND SUBSEQUENT NECROTIC DESTRUCTION OF NERVE CELLS(NEURONS) HOECHST AKTIENGESELLSCHAFT (DE) 1999-10-12 — — US disclosed
Send feedback